Cargando…
Commentary on: A call for better reporting of trials using surrogate primary endpoints
Autor principal: | Cummings, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323348/ https://www.ncbi.nlm.nih.gov/pubmed/35910669 http://dx.doi.org/10.1002/trc2.12339 |
Ejemplares similares
-
Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers
por: Manyara, Anthony Muchai, et al.
Publicado: (2022) -
A call for better reporting of trials using surrogate primary endpoints
por: Manyara, Anthony Muchai, et al.
Publicado: (2022) -
Surrogate endpoints in trials: a call for better reporting
por: Ciani, Oriana, et al.
Publicado: (2022) -
Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
por: Ciani, Oriana, et al.
Publicado: (2022) -
This Strange Being Called the Cosmos
por: Hui, Yuk
Publicado: (2021)